These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

775 related articles for article (PubMed ID: 37516898)

  • 21. Update on Pharmacotherapy in Psychodermatological Disorders.
    Shenoi SD; Soman S; Munoli R; Prabhu S
    Indian Dermatol Online J; 2020; 11(3):307-318. PubMed ID: 32695685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Daridorexant (Quviviq) for insomnia.
    Med Lett Drugs Ther; 2022 Jul; 64(1654):107-110. PubMed ID: 35802843
    [No Abstract]   [Full Text] [Related]  

  • 23. Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data.
    Solem CT; Shelbaya A; Wan Y; Deshpande CG; Alvir J; Pappadopulos E
    Neuropsychiatr Dis Treat; 2016; 12():2755-2764. PubMed ID: 27822048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacological treatment of generalized anxiety disorders: rationale and limitations].
    Boulenger JP; Capdevielle D
    Encephale; 2007; 33(1):84-94. PubMed ID: 17457298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
    Cipriani A; Zhou X; Del Giovane C; Hetrick SE; Qin B; Whittington C; Coghill D; Zhang Y; Hazell P; Leucht S; Cuijpers P; Pu J; Cohen D; Ravindran AV; Liu Y; Michael KD; Yang L; Liu L; Xie P
    Lancet; 2016 Aug; 388(10047):881-90. PubMed ID: 27289172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
    Kishi T; Ikuta T; Sakuma K; Okuya M; Hatano M; Matsuda Y; Iwata N
    Mol Psychiatry; 2023 Jan; 28(1):402-409. PubMed ID: 36253442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drugs for migraine.
    Med Lett Drugs Ther; 2023 Jun; 65(1678):89-96. PubMed ID: 37266987
    [No Abstract]   [Full Text] [Related]  

  • 28. Duloxetine versus other anti-depressive agents for depression.
    Cipriani A; Koesters M; Furukawa TA; Nosè M; Purgato M; Omori IM; Trespidi C; Barbui C
    Cochrane Database Syst Rev; 2012 Oct; 10():CD006533. PubMed ID: 23076926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis.
    Baldwin D; Woods R; Lawson R; Taylor D
    BMJ; 2011 Mar; 342():d1199. PubMed ID: 21398351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical pharmacology and use of paroxetine, a new selective serotonin reuptake inhibitor.
    Nemeroff CB
    Pharmacotherapy; 1994; 14(2):127-38. PubMed ID: 8197030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychotropic drugs in the elderly. Selection of the appropriate agent.
    Barclay AM
    Postgrad Med; 1985 Jun; 77(8):153-7, 160-2. PubMed ID: 2860641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacotherapy of generalized anxiety disorder.
    Rickels K; Rynn M
    J Clin Psychiatry; 2002; 63 Suppl 14():9-16. PubMed ID: 12562113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressants in epilepsy.
    Górska N; Słupski J; Cubała WJ; Wiglusz MS; Gałuszko-Węgielnik M
    Neurol Neurochir Pol; 2018; 52(6):657-661. PubMed ID: 30131174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An Algorithm for Generalized Anxiety Disorder.
    Abejuela HR; Osser DN
    Harv Rev Psychiatry; 2016; 24(4):243-56. PubMed ID: 27384395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Citalopram and Cannabidiol: In Vitro and In Vivo Evidence of Pharmacokinetic Interactions Relevant to the Treatment of Anxiety Disorders in Young People.
    Anderson LL; Doohan PT; Oldfield L; Kevin RC; Arnold JC; Berger M; Amminger GP; McGregor IS
    J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):525-533. PubMed ID: 34121064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison table: Some drugs for migraine prevention in adults.
    Med Lett Drugs Ther; 2023 Jun; 65(1678):e100-e102. PubMed ID: 37266989
    [No Abstract]   [Full Text] [Related]  

  • 38. Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence.
    Sproule BA; Naranjo CA; Brenmer KE; Hassan PC
    Clin Pharmacokinet; 1997 Dec; 33(6):454-71. PubMed ID: 9435993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LC-MS-MS Method for the Determination of Antidepressants and Benzodiazepines in Meconium.
    López-Rabuñal A; Lendoiro E; Concheiro M; López-Rivadulla M; Cruz A; de-Castro-Ríos A
    J Anal Toxicol; 2020 Jul; 44(6):580-588. PubMed ID: 32064503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.